Who
Tatjana Mitchell
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, Evolus.
In numbers
- Trades disclosed
- 8
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 8 Sep 2025
- Last trade
- 17 Feb 2026
- Last filed
- 19 Feb 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 17 Feb 2026filed 19 Feb 2026 | EOLS EvolusBiotechnology | SEC FORM 4 Code A | —121,489 at $0.00 | filing |
| 17 Feb 2026filed 19 Feb 2026 | EOLS Evolusoption or derivative · Biotechnology | SEC FORM 4 Code A | —121,489 at $0.00 | filing |
| 17 Feb 2026filed 19 Feb 2026 | EOLS Evolusoption or derivative · Biotechnology | SEC FORM 4 Code A | —177,471 at $0.00 | filing |
| 17 Feb 2026filed 19 Feb 2026 | EOLS Evolusoption or derivative · Biotechnology | SEC FORM 4 Code A | —121,489 at $0.00 | filing |
| 17 Feb 2026filed 19 Feb 2026 | EOLS Evolusoption or derivative · Biotechnology | SEC FORM 4 Code A | —177,471 at $0.00 | filing |
| 17 Feb 2026filed 19 Feb 2026 | EOLS EvolusBiotechnology | SEC FORM 4 Code A | —121,489 at $0.00 | filing |
| 8 Sep 2025filed 9 Oct 2025 | EOLS Evolusoption or derivative · Biotechnology | SEC FORM 4 Code A | —143,403 at $0.00 | filing |
| 8 Sep 2025filed 9 Oct 2025 | EOLS EvolusBiotechnology | SEC FORM 4 Code A | —104,603 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.